Spectral ai adds additional clinical sites to multi-center diabetic foot ulcer (dfu) study

Dallas, oct. 16, 2023 (globe newswire) -- spectral ai, inc. (nasdaq: mdai; mdaiw) (“spectral ai” or the “company”), an artificial intelligence (ai) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the addition of seven clinical sites that are currently enrolling to support the development of its diabetic foot ulcer (dfu) application for the deepview® wound imaging system. the proprietary technology combines multi-spectral imaging and ai technology to provide clinicians with an immediate healing assessment of dfu's for more accurate and timely diagnosis and therapeutic intervention.
MDAI Ratings Summary
MDAI Quant Ranking